March 18 (Reuters) - The U.S. FDA and HHS announced on Tuesday a set of actions and initiatives focused on infant formula to ensure the ongoing quality, safety, nutritional adequacy and resilience of the domestic infant formula supply.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.